Loading…
Option Care Health, Inc. is projected to rise to $25.48 by 2027, a +13% move from its current price of $22.46. OPCH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $21.94 | $22.47 | $23.02 | +0.05% |
| Aug 2 | $21.74 | $22.48 | $23.26 | +0.11% |
| Aug 3 | $21.58 | $22.50 | $23.45 | +0.16% |
| Aug 4 | $21.46 | $22.51 | $23.61 | +0.22% |
| Aug 5 | $21.35 | $22.52 | $23.76 | +0.27% |
| Aug 6 | $21.25 | $22.53 | $23.89 | +0.33% |
| Aug 7 | $21.16 | $22.55 | $24.02 | +0.38% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $21.16 | $22.55 | $24.02 | +0.38% |
| Week 2 | $20.69 | $22.63 | $24.75 | +0.76% |
| Week 3 | $20.36 | $22.72 | $25.35 | +1.15% |
| Week 4 | $20.09 | $22.80 | $25.88 | +1.53% |
| Week 5 | $19.87 | $22.89 | $26.37 | +1.92% |
| Week 6 | $19.68 | $22.98 | $26.83 | +2.31% |
| Week 7 | $19.51 | $23.07 | $27.27 | +2.70% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Option Care Health, Inc. provides home and alternate site infusion services in the United States. Its services include anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.
The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
Option Care Health, Inc. (OPCH) is a healthcare stock with a current price of $23.93 and a market cap of $3.58B, ranking 1621. The stock trades at $23.93 and carries a market cap of $3.58B, with a rank of 1621.
Forecast data show an upward price trajectory over time, starting with a 2026 avg of $23.93 and advancing to higher levels in subsequent years. Notably, the 2030 avg is $40.48 and the 2050 avg is $195.28, with corresponding ROIs of 69.1 and 716.1 respectively, indicating substantial long‑term upside as sentiment remains bullish in later years.
The 30-day technical backdrop features a bullish tilt, supported by a 14‑day RSI at 70, and price action around key moving averages. The 30-day range spans from $20.87 to $27.44, with a near-term resistance at $23.93 and a support at $20.97, set against an annualized volatility of 40%.
A major floor 13.2% below — a decisive break under it would weaken the trend.
The nearest floor, 6.6% below — buyers have tended to step in here.
The nearest ceiling, 6.5% above — a clean break opens room to run.
A major ceiling 31.2% above — clearing it would confirm fresh momentum.
Key OPCH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OPCH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $22.47 | Sell | $22.53 | Sell |
| MA 10 | $21.97 | Buy | $22.20 | Buy |
| MA 20 | $21.83 | Buy | $21.93 | Buy |
| MA 50 | $21.44 | Buy | $22.20 | Buy |
| MA 100 | $23.87 | Sell | $23.88 | Sell |
| MA 200 | $27.70 | Sell | $26.13 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.68 | Neutral |
| Stoch RSI (14) | 41.98 | Neutral |
| CCI (20) | 105.57 | Buy |
| Williams %R (14) | -51.58 | Info |
| MACD (12,26,9) | 0.16 | Buy |
| ROC (12) | 5.20 | Buy |
| Bollinger %B (20,2) | 0.76 | Neutral |
| Stochastic %K (14) | 48.42 | Neutral |
| TRIX (15) | 0.09 | Buy |
| Awesome (5,34) | 0.81 | Buy |
| Ultimate (7,14,28) | 56.81 | Neutral |
| Momentum (10) | 0.36 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 23.23 | Sell |
| ADX (14) | 10.25 | Neutral |
| ATR (14) | 0.50 | Info |
The near-term setup is described as BULLISH by the current technical reading, with RSI14 at 70 indicating strong momentum.
The price is trading above the 50-day moving average but around the vicinity of the 200-day average, as SMA50 is $21.39 and SMA200 is $27.72, while the current price stands at $23.93. This places the stock in a zone that could push toward the near-term resistance if momentum persists.
Support sits at $20.97 and resistance at $23.93, with the 30-day range spanning $20.87 to $27.44, suggesting a healthy but contested short-term trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.52 | $22.46 | $31.09 | 0% | Neutral | |
| $20.55 | $25.48 | $33.27 | +13% | Neutral | |
| $21.52 | $27.34 | $36.91 | +22% | Bullish | |
| $23.85 | $30.92 | $42.85 | +38% | Bullish | |
| $27.92 | $36.84 | $52.18 | +64% | Bullish | |
| $32.21 | $43.19 | $62.36 | +92% | Bullish | |
| $32.86 | $44.72 | $65.69 | +99% | Bullish | |
| $33.55 | $46.30 | $69.08 | +106% | Bullish | |
| $35.59 | $49.77 | $75.34 | +122% | Bullish | |
| $37.74 | $53.44 | $81.99 | +138% | Bullish | |
| $50.02 | $74.94 | $121.63 | +234% | Bullish | |
| $104.27 | $171.96 | $303.09 | +666% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $19.52 | $22.46 | $26.18 | +0.00% |
| August 2026 | $19.77 | $23.15 | $27.68 | +3.05% |
| September 2026 | $20.02 | $23.60 | $28.56 | +1.97% |
| October 2026 | $19.84 | $23.54 | $28.75 | -0.28% |
| November 2026 | $20.22 | $24.10 | $29.66 | +2.40% |
| December 2026 | $20.96 | $25.09 | $31.09 | +4.09% |
Click any year to see its month-by-month OPCH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect OPCH to range from $19.52 to $31.09 through 2026. The $22.46 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The OPCH price prediction for 2027 points to an average of $25.48 (low $20.55, high $33.27) — a potential gain of +13% on today's $22.46. Price action looks broadly range-bound.
In 2028, OPCH is projected to trade between $21.52 and $36.91, averaging $27.34 — a potential gain of +22% from today's $22.46. That is up +7% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Option Care Health, Inc.'s 2029 outlook centres on $30.92, within a $23.85 to $42.85 range. That is up +13% on the projected 2028 average. That marks a +38% change versus current levels. Momentum favours further upside here.
By 2030, OPCH could reach as high as $52.18, with a base case around $36.84 and support toward $27.92 — roughly +64% from $22.46. Buyers look set to stay in control over this stretch.
Expect OPCH to range from $32.21 to $62.36 through 2031. The $43.19 average target implies a +92% move from current prices. That is up +17% on the projected 2030 average. Momentum favours further upside here.
The OPCH price prediction for 2032 points to an average of $44.72 (low $32.86, high $65.69) — a potential gain of +99% on today's $22.46. Buyers look set to stay in control over this stretch.
In 2033, OPCH is projected to trade between $33.55 and $69.08, averaging $46.30 — a potential gain of +106% from today's $22.46. That is up +4% on the projected 2032 average. Momentum favours further upside here.
Option Care Health, Inc.'s 2034 outlook centres on $49.77, within a $35.59 to $75.34 range. That is up +7% on the projected 2033 average. That marks a +122% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, OPCH could reach as high as $81.99, with a base case around $53.44 and support toward $37.74 — roughly +138% from $22.46. Momentum favours further upside here.
Expect OPCH to range from $50.02 to $121.63 through 2040. The $74.94 average target implies a +234% move from current prices. That is up +40% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The OPCH price prediction for 2050 points to an average of $171.96 (low $104.27, high $303.09) — a potential gain of +666% on today's $22.46. Momentum favours further upside here.
Investing $1,000 in OPCH today (≈ 44.523598 OPCH) could be worth
$7,656.09
+$6,656.09 (+666%) by 2050 · US Dollar
Based on the average projected OPCH price of $171.96 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OPCHwould be worth at today's price.
$1,000 invested in OPCH on Jul 30, 2025 (≈ 32.637076 OPCH) would be worth
$733.03
-$266.97 (-26.7%) today · 0.73× · US Dollar
Based on a OPCH entry price of $30.64 vs. today's $22.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.08 | $1,065.46 | +6.5% |
| 1 month ago | $20.97 | $1,071.05 | +7.1% |
| 3 months ago | $20.03 | $1,121.32 | +12.1% |
| 6 months ago | $34 | $660.59 | -33.9% |
| 1 year ago | $30.64 | $733.03 | -26.7% |
| All time (5.0y) ago | $20.37 | $1,102.6 | +10.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OPCH forecast.
Our base-case forecast reaches $45.00 around 2033.
Implied market cap at $45.00: $6.74B
The multi-year forecast paints a rising price path with bullish sentiment broadening after 2026. In 2030, the average price is forecast at $40.48 with a return on investment of 69.1 and a bullish outlook; by 2040 the average is $85.53 with a 257.4 ROI and continued bullishness; and by 2050 the average is $195.28 with a 716.1 ROI and bullish sentiment.
Beyond 2030, the path continues higher, with 2040 showing a max of $133.57 and 2050 a max of $328.61, underscoring a substantial long-term upside if the trajectory holds. The forecast also documents continuous bullish sentiment across 2028–2050, alongside a relatively high annualized volatility of 40%.
Key year-by-year anchors include 2026 with an average of $23.93 (min $19.52, max $32.82) and 2031–2035 in the $47.34–$60.21 range, culminating in 2050's lofty targets. These figures illustrate a persistent upward thrust with meaningful upside but also acknowledge the uncertainty inherent in long-horizon forecasts.
Tap a question to reveal the answer.
2030 avg price is $40.48, with a min of $31.27 and a max of $55.96. ROI 69.1.
Forecasts show continued upside through 2026–2050, with 2026 avg $23.93, 2027 $27.50, 2028 $29.85, 2029 $34.01, 2030 $40.48, 2040 $85.53, and 2050 $195.28; ROI rises to 69.1 (2030) and 716.1 (2050) with bullish sentiment in later years.
Yes. The 2040 max is $133.57 and the 2050 max is $328.61, indicating $100 is within the forecasted upside in the coming decades.
Current price is $23.93 and market cap is $3.58B.
The 30-day range is $20.87 to $27.44, with an annualized volatility of 40%.
Option Care Health, Inc. Community Discussion
0Share your Option Care Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.